Function of Lymphocyte Homing-Associated Adhesion Molecules on Human Natural Killer and Lymphokine-Activated Killer Cells

Journal of Immunology

Volumn 158, Issue 4, 1997, Pages 1610-1617

  Uksila, Jaakko ^a   Salmi, Marko ^b   Butcher, Eugene C ^c,d   Tarkkanen, Jussi ^e   Jalkanen, Sirpa ^b  

^a TURKU UNIVERSITY   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c STANFORD UNIVERSITY   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; HERMES ANTIGEN; HOMING RECEPTOR;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; INTERPHASE; LYMPH VESSEL ENDOTHELIUM; LYMPHOCYTE ACTIVATION; LYMPHOKINE ACTIVATED KILLER CELL; METABOLISM; NATURAL KILLER CELL; PHYSIOLOGY;

ANTIGENS, CD44; ENDOTHELIUM, LYMPHATIC; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; INTERPHASE; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; RECEPTORS, IGG; RECEPTORS, LYMPHOCYTE HOMING;

EID: 0031568402     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Zöller, M., D. Bellgrau, I. Axberg, and H. Wigxell. 1982. Natural killer cells do not belong to the recirculating lymphocyte population. Scand. J. Immunol. 15: 159.
2. Fox, R. I., S. Fong, C. Tsoukas, and J. H. Vaughan. 1984. Characterization of recirculating lymphocytes in rheumatoid arthritis patients: selective deficiency of natural killer cells in thoracic duct lymph. J. Immunol. 132:2883.
3. Rolstad, B., R. B. Herberman, and C. W. Reynolds. 1986. Natural killer cell activity in the rat. V. The circulation patterns and tissue localization of peripheral blood large granular lymphocytes (LGL). J. Immunol. 136:2800.
4. MacDermott, R. P., G. O. Franclin, K. M. Jenkins, I. J. Kodner, G. S. Nash, and I. J. Weinrieb. 1980. Human intestinal mononuclear cells. I. Investigation of antibody-dependent, lectin-induced, and spontaneous cell-mediated cytotoxicity capabilities. Gastroenterology 78:47.
5. Bordignon, C., F. Villa, A. Vecchi, R. Giavazzi, M. Introna, R. Avallone, and A. Mantovani. 1982. Natural cytotoxic activity in human lungs. Clin. Exp. Immunol. 47:437.
6. Hogan, P. G., A. J. Hapel, and W. F. Doe. 1985. Lymphokine-activated and natural killer cell activity in human intestinal mucosa. J. Immunol. 135:1731.
7. Rosenberg, S. A., M. T. Lotze, L. Muul, A. E. Chang, F. P. Avis, S. Leitman, W. M. Linehan, C. N. Robertson, R. E. Lee, J. T. Rubin, C. A. Seipp, C. G. Simpson, and D. E. White. 1987. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. N. Engl. J. Med. 316:889.
8. Basse, P., R. B. Herberman, U. Nannmark, B. R. Johansson, M. Hokland, K. Wasserman, and R. H. Goldfarb. 1991. Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases. J. Exp. Med. 174:479.
9. Fisher, B., B. S. Packard, E. J. Read, J. A. Carrasquillo, C. S. Carter, S. L. Topalian, J. C. Yang, P. Yolles, S. M. Larson, and S. A. Rosenberg. 1989. Tumor localization of adoptively transferred indium-111 labeled tumor-infiltrating lymphocytes in patients with metastatic melanoma. J. Clin. Oncol. 7:250.
10. Damle, N. K., L. V. Doyle, J. R. Bender, and E. C. Bradley. 1987. Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis. J. Immunol. 138:1779.
11. Aronson, F. R., P. Libby, E. B. Brandon, M. W. Janicka, and J. W. Mier. 1988. IL-2 rapidly induces natural killer cell adhesion to human endothelial cells: a potential mechanism for endothelial injury. J. Immunol. 141:158.
12. Cotran, R. S., J. S. Pober, M. A. Gimbrone, Jr., T. A. Springer, E. A. Wiebke, A. A. Gaspari, S. A. Rosenberg, and M. T. Lotze. 1987. Endothelial activation during interleukin 2 immunotherapy: a possible mechanism for the vascular leak syndrome. J. Immunol. 139:1883.
13. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272:60.
14. Berg, E. L., K. M. Robinson, R. A. Warnock, and E. C. Butcher. 1991. The human peripheral lymph node vascular addressin is a ligand for LECAM-1, the peripheral lymph node homing receptor. J. Cell Biol. 114:343.
15. Baumhueter, S., M. S. Singer, W. Henzel, S. Hemmerich, M. Renz, S. D. Rosen, and L. A. Lasky. 1993. Binding of L-selectin to the vascular sialomucin CD34. Science 262:436.
16. 7 integrin mediates lymphocyte binding to mucosal vascular addressin MAdCAM-1. Cell 74:185.
17. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301.
18. Elices, M. J., L. Osborn, Y. Takada, C. Crouse, S. Luhowskyj, M. E. Hemler, and R. R. Lobb. 1990. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from VLA-4/fibronectin binding site. Cell 60:577.
19. Jalkanen, S., R. F. Bargatze, J. de los Toyos, and E. C. Butcher. 1987. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J. Cell Biol. 105:983.
20. Pals, S. T., F. Hogervorst, G. D. Keizer, T. Thepen, E. Horst, and C. C. Figdor. 1989. Identification of a widely distributed 90-kDa glycoprotein that is homologous to the hermes-1 human lymphocyte homing receptor. J. Immunol. 143:851.
21. Camp, R. L., A. Scheynius, C. Johansson, and E. Puré. 1993. CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J. Exp. Med. 178:497.
22. Timonen, T., and E. Saksela. 1980. Isolation of human NK cells by density gradient centrifugation. J. Immunol. Methods 36:285.
23. Sanchez-Madrid, F., A. M. Krensky, C. F. Ware, E. Robbins, J. L. Strominger, J. S. Burakoff, and T. A. Springer. 1982. Three distinct antigens associated with human T-lymphocyte-mediatedcytolysis: LFA-1, LFA-2, and LFA-3. Proc. Natl. Acad. Sci. USA 79:7489.
24. Sanchez-Madrid, F., A. M. Krensky, C. F. Ware, E. Robbins, J. L. Strominger, S. J. Burakoff, and T. A. Springer. 1982. Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc. Natl. Acad. Sci. USA 79:7489.
25. Dana, N., B. Styrt, J. D. Griffin, R. F. Todd III, M. S. Klempner, and M. A. Arnaout. 1986. Two functional domains in the phagocyte membrane glycoprotein Mo1 identified with monoclonal antibodies. J. Immunol. 137:3259.
26. Koopman, G., K.-H. Heider, E. Horst, G. R. Adolf, F. van den Berg, H. Ponta, P. Herrlich, and S. T. Pals. 1993. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J. Exp. Med. 177:897.
27. Kishimoto, T. K., M. A. Jutila, and E. C. Butcher. 1990. Identification of a human peripheral lymph node homing receptor: a rapidly down-regulated adhesion molecule. Proc. Natl. Acad. Sci. USA 87:2244.
28. 7 mediated adhesion to vascular cell adhesion molecule-1, mucosal addressin-1, fibronectin and lymphocyte aggregation. J. Immunol. 153:3847.
29. Sanchez-Madrid, F., O. de Landazuri, C. Morago, M. Cebian, A. Acevedo, and C. Bernabeu. 1986. VLA-3, a novel polypeptide associated within the VLA molecular complex, cell distribution and biochemical characterization. Eur. J. Immunol. 16:1343.
30. Salmi, M., D. P. Andrew, E. C. Butcher, and S. Jalkanen. 1995. Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanism. J. Exp. Med. 181:137.
31. Jalkanen, S. T., and E. C. Butcher. 1985. In vitro analysis of the homing properties of human lymphocytes: developmental regulation of functional receptors for high endothelial venules. Blood 66:577.
32. Wu, N. W., S. Jalkanen, P. Streeter, and E. C. Butcher. 1988. Evolutionary conservation of tissue-specific lymphocyte-endothelial cell recognition mechanisms involved in lymphocyte homing. J. Cell Biol. 107:1845.
33. Salmi, M., and S. Jalkanen. 1996. Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells. J. Exp. Med. 183:569.
34. Bender, J. R., R. Pardi, M. A. Karasek, and E. G. Engleman. 1987. Phenotypic and functional characterization of lymphocytes that bind human microvascular endothelial cells in vitro. J. Clin. Invest. 79:1679.
35. Allavena, P., C. Paganin, I. Martin-Padura, G. Peri, M. Gaboli, E. Dejana, P. C. Marchisio, and A. Mantovani. 1991. Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium. J. Exp. Med. 173:439.
36. Allavena, P., C. Paganin, D. Zhou, C. Bianchi, S. Sozzoni, and A. Mantovani. 1994. Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood 84:2261.
37. Robertson, M. J., M. A. Caligiuri, T. J. Manley, H. Levine, and J. Ritz. 1990. Human natural killer cell adhesion molecules: differential expression after activation and participation in cytolysis. J. Immunol. 145:3194.
38. Steen, P. D., J. R. McGregor, C. M. Lehman, and W. E. Samlowski. 1989. Changes in homing receptor expression on murine lymphokine-activated killer cells during IL-2 exposure. J. Immunol. 143:4324.
39. Bianchi, G., M. Sironi, E. Ghibaudi, C. Selvaggini, M. Elices, P. Allavena, and A. Mantovani. 1993. Migration of natural killer cells across endothelial cell monolayers. J. Immunol. 151:5135.
40. Gismondi, A., S. Morrone, M. J. Humphries, M. Piccoli, L. Frati, and A. Santoni. 1991. Human natural killer cells express VLA-4 and VLA-5, which mediate their adhesion to fibronectin. J. Immunol. 146:384.
41. Mäenpää, A., J. Jääskeläinen, O. Carpen, M. Patarroyo, and T. Timonen. 1993. Expression of integrins and other adhesion molecules on NK cells; impact of IL-2 on short-and long-term cultures. Int. J. Cancer 53:850.
42. 1-integrin expression and function. J. Immunol. 152:446.
43. Sconocchia, G., J. A. Titus, and D. M. Segal. 1994. CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells. J. Immunol. 153:5473.